Skip to main content

Vibalogics Modular BSL-2LS

Vibalogics Modular BSL-2LS


Modular BSL-2LS cGMP Facility

Vector production

Boxborough, MA

Prefabricated Viral Vector Modular BSL-2LS cGMP Facility Designed, Built, Installed and Commissioned in 13 Months

When Vibalogics, a German-based CDMO, sought out Germfree, it was at a pivotal point in its business development. As the company looked for ways to expand its reach into the U.S. CDMO market for viral vectors, it needed a facility with a larger footprint capable of supporting three processing lines up to 2 x 2,000 liters in size with fill finish capacity.
Project features

Size: 12,000 sq. ft. of cleanroom and mezzanine space

Layout configurations: 9 prefabricated modules, open ballroom concept with a high hat to accommodate 2 X 2000L bioreactors

Facilities/Equipment: Cleanroom for unidirectional process flow, flexible utilities, removable window and door panels

The challenge

Germfree was awarded the opportunity to design and fabricate a modular BSL-2LS cGMP facility that accommodated the desired scale while ensuring unidirectional process flow and comprehensive engineering controls.

The answer

Germfree provided an innovative solution by designing and manufacturing a modular BSL-2LS cGMP facility consisting of 9 prefabricated modules. The facility includes approximately 12,000 sq. ft. of cGMP manufacturing and mechanical mezzanine space and incorporates an open ballroom concept with a high hat to accommodate 2 X 2000L bioreactors. The facility layout incorporates strong segregation to support multiple campaigns occurring at the same time.

Given the nature of starting materials and the substrates/agents being manufactured, this facility was built to meet the Center for Disease Control (CDC) guidelines for biosafety level 2 Large Scale (BSL-2LS). The facility has onboard VHP distribution that allows for manufacturing suites to be biodecontaminated between campaigns as an added risk control.

Prefabricated modules supported the accelerated timeline by manufacturing the cleanrooms while the primary site was under demolition and renovation. This reduced the overall project duration by several months.

Germfree’s team of experts created a state-of-the-art BSL-2LS cGMP facility that was carefully engineered to provide unidirectional process flow and robust primary engineering controls to ensure a safe and efficient working environment. The facility was designed with configurable utilities and removable window/door panels. In addition, the plant’s flexible design allows it to adapt to the ever-changing needs of a CDMO.

This facility was built using Germfree’s proven modular cleanroom platform, click here to learn more about our modular cleanrooms.


Read about the unique process we used to deliver this project and how we can deliver yours.

Learn about our process

You might also be interested in


An Engineering Perspective: Challenges Associated with Building New Isolator Technology (AST x Germfree)

Paula Rizo, Mechanical Engineering Lead for Equipment, delves into the groundbreaking features of Germfree and AST's latest collaboration.

Kevin Kyle’s Vision: Transforming Industry Standards through Germfree and AST’s Revolutionary Collaboration

Kevin Kyle, Germfree’s CEO, shares the first look at Germfree and AST’s revolutionary collaboration, unveiling a cutting-edge isolator that is set to redefine standards in the pharmaceutical industry.
User gowning in mirror

Leveraging Current Technology and Regulatory Frameworks to Deliver Patient Access Today

Leveraging Current Technology and Regulatory Frameworks to Deliver Patient Access Today

Contact us: Let's unlock your scientific potential together

Complete our contact form and a member of our commercial team will contact you within 24 hours.

White email icon on a green diamond

Service & support: